sacituzumab
Gilead
['choice i', 'sacituzumab', 'breast', 'sacitu, govi']
sacituzumab govitecan outperformed treatment of physician s choice in overall survival benefit at final clinical follow-up. #asco2023 #breast #cancer read more: 
Cancer Nursing Today delivers the latest in cancer news and published literature, providing cancer nurses access to curated topics.